GABRA2
protein-codinggamma-aminobutyric acid type A receptor subunit alpha2, the group of Gamma-aminobutyric acid type A receptor subunits
Gene summary
GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~231.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0032812
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0018614
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0032812
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0032812
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0032812
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GABRA2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000807.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 72 | 75 | |||
| missense | 3 | 18 | 117 | 25 | 2 | 165 |
| nonsense | 1 | 5 | 6 | |||
| start loss | 0 | |||||
| frameshift | 2 | 8 | 10 | |||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 5 | 19 | 138 | 97 | 2 | 261 |
Highest pathogenic variant AF is 0.000002000248
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000798.2 | 9 | MANE Select | |
| Ensembl | ENSP00000371033.4 | 9 | MANE Select | |
| RefSeq | NP_001107647.1 | 9 | Standard | |
| RefSeq | NP_001273756.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| gabra2a | Danio rerio | Structure: third ventricle Quality: apoptotic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Retrograde endocannabinoid signaling - Homo sapiens (human)
- GABAergic synapse - Homo sapiens (human)
- Nicotine addiction - Homo sapiens (human)
- Neuroactive ligand-receptor interaction - Homo sapiens (human)
- Taste transduction - Homo sapiens (human)
Biological Process
- regulation of neurotransmitter levels
- neurotransmitter transport
- signal transduction
- gamma-aminobutyric acid signaling pathway
- chemical synaptic transmission
Molecular Function
- GABA-A receptor activity
- extracellular ligand-gated ion channel activity
- inhibitory extracellular ligand-gated ion channel activity
- chloride channel activity
- benzodiazepine receptor activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- cell junction
- integral component of synaptic vesicle membrane
- dendrite membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000510861
- Coding exons
- 9
- Length
- 226804
- Individuals with no LoFs
- 125657
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125661
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.13 | 97 | 231 | 0.420 | 0.0000110 | 2970 |
| Missense (PolyPhen) | 17 | 107.67 | 0.15788 | 1427 | ||
| Synonymous | 0.493 | 77 | 82.7 | 0.931 | 0.00000414 | 858 |
| Loss of Function | 4.01 | 1 | 20.7 | 0.0483 | 9.94e-7 | 259 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000036 | 0.000035 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.;
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- LoFtool
- 0.167
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 33.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.164
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |